Picture of Zhaoke Ophthalmology logo

6622 — Zhaoke Ophthalmology News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Zhaoke Ophthalmology Says Approval Of Investigational New Drug Application By NMPA

Aug 12 (Reuters) - Zhaoke Ophthalmology Ltd  6622.HK :
    * APPROVAL OF INVESTIGATIONAL NEW DRUG APPLICATION FOR PHASE
III
CLINICAL TRIAL OF CYCLOSPORINE A (CSA) OPHTHALMIC GEL BY NMPA


Further company coverage:  6622.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zhaoke Ophthalmology

See all news